[#item_full_content]
Author:
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study
[#item_full_content]AACHEN, Germany–(BUSINESS WIRE)– #CerebralProtection–Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the…
[#item_full_content]